Don’t use the ‘C-word’

Cancer remains one of the leading causes of death worldwide, with over 600,000 people dying from it annually in the United States alone—equivalent to the population of a mid-sized city. While the word 'cancer' often evokes fear of pain, suffering, and death, the reality is more nuanced. More than 2 million Americans receive a cancer diagnosis each year, yet for many, the condition poses little to no threat to their lifespan or quality of life. However, the label itself carries significant consequences, including psychological distress, social stigma, and economic burdens such as higher insurance costs. Treatments like surgery or radiation can also lead to permanent side effects, such as impaired urinary, bowel, or sexual function. The disconnect between the word's connotations and its actual implications has sparked debates about how we define and communicate cancer.

Cancer is fundamentally different from other diseases because it originates from the body's own cells behaving abnormally. Unlike infections caused by external invaders like viruses or bacteria, cancer involves cells that grow too quickly and spread to other parts of the body. These cells are still part of the self, making treatment challenging. Chemotherapy, for example, is more toxic than antibiotics because it struggles to distinguish between normal and cancerous cells within the body. The term 'cancer' comes from the Greek word karkinos, meaning 'crab,' named by Hippocrates in the 5th century BCE for the visible tendrils of tumors spreading under the skin. Over centuries, advancements like microscopy have allowed scientists to study cancer at a cellular level, but the core issue remains: cancer cells are the body's own cells gone rogue.

Historically, cancer was diagnosed only when it caused visible symptoms, such as lumps, pain, or weight loss. By the time it was detected, it was often advanced and difficult to treat. The mid-20th century marked a shift with the introduction of cancer screening programs, such as Pap smears for cervical cancer in the 1950s, mammography for breast cancer in the 1960s, and prostate-specific antigen (PSA) testing for prostate cancer in the 1990s. These screenings allowed cancers to be detected years or even decades before they caused symptoms, often through biopsies. However, this shift also led to a new problem: overdiagnosis, where harmless or slow-growing tumors are identified and treated unnecessarily. This has resulted in overtreatment, causing side effects and increased healthcare costs.

The word 'cancer' carries immense psychological weight, often overshadowing the actual risk posed by a diagnosis. Patients like William, who received a prostate cancer diagnosis labeled as 'grade group 1'—a slow-growing, low-risk tumor—experienced severe anxiety despite the minimal threat to their health. The term itself triggers fear and can lead to rushed treatment decisions, even when active surveillance might be a safer option. The disconnect between the word's cultural meaning and its biological reality has led some specialists to question whether the term 'cancer' should be redefined or replaced. The goal is to align the diagnosis with what patients actually need to know about their health risks.

Cancer arises from the body's own cells due to genetic mutations that allow uncontrolled growth and spread. Every day, trillions of cells in the human body divide, and errors in DNA copying can occur. While most of these errors are corrected, some slip through, leading to rogue cells. The immune system normally identifies and destroys these cells, but over time, some mutations evade detection and form tumors. Most of these early events do not result in clinically meaningful cancer because they lack the ability to cause symptoms or spread. However, some tumors acquire additional mutations that accelerate growth and impair error-checking, allowing cancer to progress. This process is a constant arms race between cells and the immune system.

Cancer is rooted in the ancient imperative of cells to reproduce and survive, a trait inherited from single-celled organisms that dominated Earth for 2 billion years. Multicellular life evolved when cells began cooperating, giving up their independence to form complex organisms like humans. However, each cell retains its primordial drive to replicate, which is normally kept in check by genetic controls and interactions with other cells. Cancer occurs when these controls fail, and cells revert to their single-celled behavior, prioritizing their own reproduction over the health of the organism. This tension between individual cell behavior and the needs of the whole body explains why cancer is so difficult to treat.